A Case Study in Missing the Mark –

[ad_1] I recently caught a TV spot for Rezdiffra, a treatment for fatty liver disease, and it perfectly encapsulates what’s fundamentally broken about direct-to-consumer (DTC) pharma advertising today. Here’s the problem: The ad jumps straight to branded messaging without any patient education or disease awareness building. No context. No foundation. Just a drug name and…

Read More